In summary, we showed that silencing UBQLN1 reduces cell viability and increases caspase-3 activity and overexpression of UBQLN1 lowers Aβ levels, supporting a loss of function mechanism of UBQLN1 in AD. Here, CASP3 is linked to Alzheimer disease.